Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-11-20FDA Approved: SEVELAMER CARBONATE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's generic sevelamer carbonate for the management of hyperphosphatemia in patients with c…
-
FDA approval · 2020-11-17FDA Approved: CALCIUM ACETATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for calcium acetate capsules (667 mg) by Rising Pharma Holdings, Inc.
-
EMA approval · 2020-09-18New treatment for children with chronic kidney disease
The EMA announces a new treatment option for children with chronic kidney disease, expanding available therapies for pediatric patients.
-
FDA approval · 2020-09-15FDA Approved: DOXERCALCIFEROL — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves an original ANDA for doxercalciferol (generic) manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2020-09-11FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) filed by Fresenius Medical Care Holdings, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2020-06-26New treatment to enable kidney transplant in highly sensitised patients
The EMA reports a new treatment that can enable kidney transplantation in highly sensitised patients, addressing a population with limited o…
-
FDA approval · 2020-05-31FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
FDA approves a supplemental ANDA for furosemide from Solco Healthcare LLC.
-
FDA approval · 2020-05-11FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) from Takeda Pharmaceuticals America, expanding its labeling.
-
FDA approval · 2020-05-11FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2020-05-05FDA Approved: FARXIGA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Farxiga (dapagliflozin) from AstraZeneca, adding/ updating labeling to reflect a new indication …
-
FDA approval · 2020-04-30FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Sevelamer carbonate submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2020-03-31FDA Approved: FERRLECIT — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for Ferrlecit (sodium ferric gluconate complex) submitted by Sanofi-Aventis U.S. LLC, updating label…
-
FDA approval · 2020-02-28FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) submitted by Fresenius Medical Care Renal Therapies Grou…
-
FDA approval · 2020-02-21FDA Approved: CALCIUM ACETATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for calcium acetate capsules (667 mg) from Rising Pharma Holdings, Inc., a generic product.
-
FDA approval · 2020-02-07FDA Approved: DOXERCALCIFEROL — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves the original ANDA for doxercalciferol, a generic vitamin D analog from Meitheal Pharmaceuticals, for the treatment of secondary…
-
FDA approval · 2019-10-11FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
The FDA approved a supplemental application for FERAHEME (ferumoxytol) submitted by AMAG Pharmaceuticals, Inc., indicating an updated labeli…
-
FDA approval · 2019-09-26FDA Approved: DOXERCALCIFEROL — Original Application (Gland Pharma Limited)
FDA approved Gland Pharma Limited's original application for a generic doxercalciferol product.
-
FDA approval · 2019-07-24FDA Approved: PARICALCITOL — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for paricalcitol from Eugia US LLC. Paricalcitol is a vitamin D analog used to treat secondary h…
-
FDA approval · 2019-03-08FDA Approved: PARSABIV — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for Parsabiv (etelcalcetide) from Amgen, Inc. The document records the agency's action on Amgen's su…
-
FDA approval · 2019-02-21FDA Approved: CALCITRIOL — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a generic calcitriol product from Sun Pharmaceutical Industries under an original ANDA, enabling another generic calcitriol opt…
-
FDA approval · 2019-02-08FDA Approved: SEVELAMER HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Sevelamer hydrochloride as a generic product under an original ANDA from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2018-12-19FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc.
-
FDA approval · 2018-11-20FDA Approved: CALCIUM ACETATE — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for Calcium Acetate from Chartwell RX, LLC.
-
FDA approval · 2018-11-08FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda, resulting in updated labeling for managing h…
-
FDA approval · 2018-11-08FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc. The update pertains…